{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Mylan Inc", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Perrigo Company", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/28/business/dealbook/fear-keeps-traders-on-sidelines-of-drug-mega-deals.html", "document_type": "article", "byline": {"person": [{"lastname": "CYRAN", "firstname": "Robert", "role": "reported", "organization": "", "rank": 1}, {"lastname": "UNMACK", "firstname": "Neil", "role": "reported", "organization": "", "rank": 2}], "original": "By ROBERT CYRAN and NEIL UNMACK"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "413", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Huge hostile deals are usually catnip for arbitrageurs, but the latest battles come with cross-border complexity, antitrust concerns and a poison pill, Robert Cyran and Neil Unmack of Reuters Breakingviews write.", "pub_date": "2015-04-28T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Breakingviews", "main": "Fear Keeps Traders on Sidelines of Drug Mega-Deals", "content_kicker": "Breakingviews"}, "print_page": "", "snippet": "Huge hostile deals are usually catnip for arbitrageurs, but the latest battles come with cross-border complexity, antitrust concerns and a poison pill, Robert Cyran and Neil Unmack of Reuters Breakingviews write.", "_id": "553e740e38f0d8592c70c108", "slideshow_credits": null, "abstract": null}